Methods of managing levodopa-induced dyskinesias

Drug Safety

Volumn 14, Issue 6, 1996, Pages 365-374

  Giron Jr , Louis T ^a,b   Koller, William C ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; BROMOCRIPTINE; BUSPIRONE; CABERGOLINE; CARBIDOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; LEVODOPA; PERGOLIDE; TERGURIDE;

AGRANULOCYTOSIS; BRAIN DEPTH STIMULATION; CLINICAL TRIAL; DISEASE CLASSIFICATION; DOPAMINERGIC SYSTEM; DRUG BLOOD LEVEL; DRUG EFFICACY; DYSKINESIA; DYSTONIA; FUNCTIONAL DISEASE; HALLUCINATION; HUMAN; HYPERSALIVATION; INTRAVENOUS DRUG ADMINISTRATION; NIGHTMARE; NONHUMAN; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; SEDATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029945525     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199614060-00002     Document Type: Review

References (35)

1. Koller WC, Silver DE, Lieberman A. An algorithm for the management of Parkinson's disease. Neurology 1994; 44 Suppl. 10:S1-S52
2. Poewe WH. Clinical aspects of motor fluctuations in Parkinson's disease. Neurology 1944; 44 Suppl. 6; S6-9
3. Marsden CD, Parkes JD, Quinn N. Fluctuations of disability in Parkinson's disease: clinical aspects. In: Marsden CD, Fahn S, editors. Movement disorders. London: Butterworths, 1982: 96-122
4. Juncos JL, Mouradian MM, Fabbrinni G, et al. Levodopa infusion therapy. In: Koller WC, Paulson G, editors Therapy of Parkinson's disease. New York: Marcel Dekker, Inc., 1990: 185-203
5. Gancher ST, Nutt JG, Woodward WR. Peripheral pharmacokinetics of levodopa in untreated, stable and fluctuating parkinsonian patients. Neurology 1987 Jun; 37 (6): 940-4
6. Nutt JG, Woodward WR. Levodopa pharmacokinetics and pharmacodynamics in fluctuating parkinsonian patients. Neurology 1986 Jun; 36 (6): 739-44
7. Cotzias GC. Levo-dopa in Parkinson's disease. Hosp Pract 1969; 4: 35-41
8. Schuh LA, Bennett JP. Suppression of dyskinesias in Parkinson's disease I: continuous intravenous levodopa shifts the dose-response for production of dyskinesias hut not for relief of parkinsonism in patients with advanced Parkinson's disease. Neurology 1993; 43: 1545-50
9. Mouradian MM, Heuser JJE, Baronti F, et al. Pathogenesis of dyskinesias in Parkinson's disease. Ann Neurol 1989; 25: 523-6
10. Nutt JG. Pharmacokinetics and pharmacodynamics of levodopa: clinical implications. In: Koller WC, editor. Handbook of Parkinson's disease. 2nd rev. ed. New York: Marcel Dekker, Inc., 1992: 411-31
11. Nutt JG. Levo-dopa-induced dyskinesia: review, observations and speculations. Neurology 1990; 40: 340-5
12. Muenter MD, Sharpless NS, Tyce GM, et al. Patterns of dystonia ('I-D-I' and 'D-I-D') in response to L-dopa therapy for Parkinson's disease. Mayo Clin Proc 1977; 52: 163-74
13. Luquin MR, Scipioni O, Vaamonde J, et al. Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification. Mov Disord 1992; 7: 117-24
14. Pahwa R, Busenbark K, Huber SJ. Clinical experience with controlled-release levodopa/carbidopa in Parkinson's disease. Neurology 1993; 43: 677-81
15. Rodnitzky RL. The use of Sinemet CR in the management of mild to moderate Parkinson's disease. Neurology 1992; 42 Suppl. 1: 44-50
16. Rajput AN, Rozdilsky B, Rajput A. Levodopa efficacy and pathologic basis of parkinson syndrome. Clin Neuropharmacol 1990; 13: 553-8
17. Kurth MC, Tetrud JW, Irwin I. Oral levodopa/carbidopa solution vs tablets in Parkinson's disease with severe fluctuations: a pilot study. Neurology 1993; 43: 1036-9
18. Bonifati V, Fabrizio E, Cipriani R, et al. Buspirone in levodopa-induced dyskinesias. Clin Neuropharmacol 1994; 17: 73-82
19. Kleedorfer B, Lees AJ, Stern GM. Buspirone in the treatment of levodopa induced dyskinesias [letter]. J Neurol Neurosurg Psychiatry 1991; 54: 376-7
20. Bennett JP, Landow ER, Dietrich S, et al. Suppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction. Mov Disord 1994; 9: 409-14
21. Duril F, Vidailet M, Bonnet AM, et al. Levodopa-induced dyskinesias are improved by fluoxetine. Neurology 1945; 45: 1855-8
22. Steur ENHJ. Increase of Parkinson disability after fluoxetine medication. Neurology 1993; 43: 211-3
23. Baronti F, Mouradian MM, Conant KE, et al. Partial dopamine agonist therapy of levodopa-induced dyskinesias. Neurology 1992; 42: 1241-3
24. Page RD. The use of thalamotomy in the treatment of levodopa-induced dyskinesias. Acta Neurochir 1992; 114: 77-117
25. Shelby G. Stereotactic Surgery. In: Koller WC, editor. Handbook of Parkinson's Disease. 2nd ed. New York: Marcel Dekker, Inc., 1992: 421-35
26. Blond S, Caparros-Lefebvre D, Parker F, et al. Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J Neurosurg 1992; 77, 62-8
27. Caparros-Lefebvre D, Blond S, Vermersch P, et al. Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease. J Neurol Neurosurg Psychiatry 1993; 56: 268-73
28. Lieberman A. Bromocriptine in Parkinson's Disease. In: Koller WC, Paulson G, editors. Therapy of Parkinson's Disease. New York: Marcel Dekker, Inc., 1990: 225-67
29. Tolosa E, Valldeoriola F, Marti MJ. New and emerging strategies for improving levodopa treatment. Neurology 1994; 44 Suppl. 6: S35-44
30. Hardie RJ, Lees AJ, Stern GM. On/off fluctuations in Parkinson's disease: a clinical and neuropharmacological study. Brain 1984; 107 (Pt 2): 487-506
31. Marion MH, Stocchi F, Quinn NP, et al. Repeated levodopa infusions in fluctuating Parkinson's disease: clinical and pharmacokinetic data. Clin Neuropharmacol 1986; 9 (2): 165-81
32. Steiger MJ, Quinn NP. Levodopa-based therapy. In: Koller WC, editor. Handbook of Parkinson's disease. 2nd rev. ed. New York. Marcel Dekker, Inc., 1992: 391-410
33. Obeso JA, Luquin MR, Martinez Lage JM. Intravenous lisuride corrects oscillations of motor performance in Parkinson's disease. Ann Neurol 1986; 19: 31-5
34. Kaye JA, Feldman RG. The role of L-DOPA holiday in the long-term management of Parkinson's disease. Clin Neuropharmacol 1986; 9: 1-13
35. Mayeux R, Stern Y, Mulvey K, et al. Reappraisal of temporary levodopa withdrawal ('drug holiday') in Parkinson's disease. N Engl J Med 1985; 313: 724-8